David brings over 30 years of executive level experience dedicated to MedTech to Trinity. He has experience across strategy consulting, transaction advisory, venture investing, as well as HEOR, market access and clinical affairs advisory all focused on device, diagnostics and digital health.

Before joining Trinity David led MedTech portfolio and investing at General Inception, a venture capital firm. Prior to that, Dave spent five years leading the MedTech practice as Senior Partner at Alira Health, a global advisory firm with practices across all healthcare consulting and execution.

In previous roles David led Business Development for a $5B division of Medtronic (legacy Covidien) in their respiratory, monitoring and med/surg products covering 22 business lines. He ran deals in M&A, distribution, co-development and also executed minority equity investments. Prior to Medtronic, David was Director of Corporate Development at Hologic running strategy and executing deals across gyn surgery, breast health, and molecular diagnostics.

David also has managed Boston Scientific’s strategy and business development function in vascular surgery, interventional medicine and oncology. He has held management roles at Integra Lifesciences directing neuromonitoring and neurosurgery business units. David initiated his career with Abbott Labs in their Diagnostics Division in global market intelligence as an internal consultant, identifying and prioritizing market expansion and development segments.

David has a BA degree from Clark University and an MBA from Thunderbird Global School of International Management.